Trevi Therapeutics, Inc. (TRVI) Free cash flow 2018–2025
Trevi Therapeutics, Inc. (TRVI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$42.1MFY2025 · since FY2018: -$18.4M → -$42.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$42.1M | -10.0% |
| FY2024 | -$38.3M | -20.2% |
| FY2023 | -$31.8M | -12.4% |
| FY2022 | -$28.3M | — |
| FY2020 | -$29.0M | -25.7% |
| FY2019 | -$23.1M | -25.2% |
| FY2018 | -$18.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice